Sime Armoyan - Net Worth and Insider Trading

Sime Armoyan Net Worth

The estimated net worth of Sime Armoyan is at least $196 Million dollars as of 2024-04-29. Sime Armoyan is the 10% Security Holder of Morguard Corp and owns about 1,111,127 shares of Morguard Corp (TSX:MRC) stock worth over $123 Million. Sime Armoyan is also the 10% Security Holder of Knight Therapeutics Inc and owns about 12,755,300 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $73 Million. Details can be seen in Sime Armoyan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sime Armoyan has not made any transactions after 2024-04-15 and currently still holds the listed stock(s).

Transaction Summary of Sime Armoyan

To

Sime Armoyan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sime Armoyan owns 1 companies in total, including Knight Therapeutics Inc (TSX:GUD) .

Click here to see the complete history of Sime Armoyan’s form 4 insider trades.

Insider Ownership Summary of Sime Armoyan

Ticker Comapny Transaction Date Type of Owner
TSX:GUD Knight Therapeutics Inc 2024-04-11 10% Security Holder

Sime Armoyan Latest Holdings Summary

Sime Armoyan currently owns a total of 2 stocks. Among these stocks, Sime Armoyan owns 1,111,127 shares of Morguard Corp (TSX:MRC) as of April 15, 2024, with a value of $123 Million and a weighting of 62.64%. Sime Armoyan also owns 12,755,300 shares of Knight Therapeutics Inc (TSX:GUD) as of April 11, 2024, with a value of $73 Million and a weighting of 37.36%.

Latest Holdings of Sime Armoyan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:MRC Morguard Corp 2024-04-15 1,111,127 110.30 122,557,308
TSX:GUD Knight Therapeutics Inc 2024-04-11 12,755,300 5.73 73,087,869

Holding Weightings of Sime Armoyan


Sime Armoyan Form 4 Trading Tracker

According to the SEC Form 4 filings, Sime Armoyan has made a total of 1 transactions in Morguard Corp (TSX:MRC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Morguard Corp is the acquisition of 100 shares on April 15, 2024, which cost Sime Armoyan around $10,990.

According to the SEC Form 4 filings, Sime Armoyan has made a total of 1 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Knight Therapeutics Inc is the sale of 10,900 shares on April 11, 2024, which brought Sime Armoyan around $64,855.

Insider Trading History of Sime Armoyan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sime Armoyan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sime Armoyan Ownership Network

Ownership Network List of Sime Armoyan

No Data

Ownership Network Relation of Sime Armoyan


Sime Armoyan Owned Company Details

What does Knight Therapeutics Inc do?

Who are the key executives at Knight Therapeutics Inc?

Sime Armoyan is the 10% Security Holder of Knight Therapeutics Inc.

Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary

Over the past 18 months, Sime Armoyan made 1 insider transaction in Knight Therapeutics Inc (TSX:GUD) with a net sale of 10,900.

In summary, during the past 3 months, insiders sold 10,900 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 0 shares, with a net sale of 10,900 shares. During the past 18 months, 10,900 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 10,900 shares.

Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Knight Therapeutics Inc Insider Transactions

No Available Data

Sime Armoyan Mailing Address

Above is the net worth, insider trading, and ownership report for Sime Armoyan. Currently GuruFocus does not have mailing address information for Sime Armoyan.

Discussions on Sime Armoyan

No discussions yet.